nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetrorelix—Degarelix—prostate cancer	0.236	0.602	CrCtD
Cetrorelix—Goserelin—prostate cancer	0.156	0.399	CrCtD
Cetrorelix—LHCGR—Goserelin—prostate cancer	0.145	0.468	CbGbCtD
Cetrorelix—GNRHR—Degarelix—prostate cancer	0.105	0.338	CbGbCtD
Cetrorelix—GNRHR—Goserelin—prostate cancer	0.0604	0.194	CbGbCtD
Cetrorelix—Ceruletide—Degarelix—prostate cancer	0.0418	0.171	CrCrCtD
Cetrorelix—Goserelin—Degarelix—prostate cancer	0.037	0.152	CrCrCtD
Cetrorelix—Nafarelin—Degarelix—prostate cancer	0.0332	0.136	CrCrCtD
Cetrorelix—Degarelix—Goserelin—prostate cancer	0.032	0.131	CrCrCtD
Cetrorelix—Gonadorelin—Degarelix—prostate cancer	0.0302	0.124	CrCrCtD
Cetrorelix—Ceruletide—Goserelin—prostate cancer	0.0277	0.114	CrCrCtD
Cetrorelix—Nafarelin—Goserelin—prostate cancer	0.022	0.0902	CrCrCtD
Cetrorelix—Gonadorelin—Goserelin—prostate cancer	0.02	0.0821	CrCrCtD
Cetrorelix—Ovarian hyperstimulation syndrome—Goserelin—prostate cancer	0.00255	0.0865	CcSEcCtD
Cetrorelix—Developmental delay—Estramustine—prostate cancer	0.00126	0.0426	CcSEcCtD
Cetrorelix—Congenital anomaly—Estramustine—prostate cancer	0.00126	0.0426	CcSEcCtD
Cetrorelix—Contusion—Abiraterone—prostate cancer	0.000532	0.018	CcSEcCtD
Cetrorelix—Local reaction—Ethinyl Estradiol—prostate cancer	0.000467	0.0158	CcSEcCtD
Cetrorelix—Congenital anomaly—Estradiol—prostate cancer	0.000444	0.015	CcSEcCtD
Cetrorelix—Developmental delay—Estradiol—prostate cancer	0.000444	0.015	CcSEcCtD
Cetrorelix—Injection site reaction—Degarelix—prostate cancer	0.000376	0.0128	CcSEcCtD
Cetrorelix—Hot flush—Estramustine—prostate cancer	0.000371	0.0126	CcSEcCtD
Cetrorelix—Menopausal symptoms—Estramustine—prostate cancer	0.000367	0.0125	CcSEcCtD
Cetrorelix—Hot flush—Abiraterone—prostate cancer	0.00036	0.0122	CcSEcCtD
Cetrorelix—Menopausal symptoms—Abiraterone—prostate cancer	0.000357	0.0121	CcSEcCtD
Cetrorelix—Hot flush—Nilutamide—prostate cancer	0.000329	0.0111	CcSEcCtD
Cetrorelix—Hot flush—Flutamide—prostate cancer	0.000327	0.0111	CcSEcCtD
Cetrorelix—Menopausal symptoms—Nilutamide—prostate cancer	0.000326	0.011	CcSEcCtD
Cetrorelix—Menopausal symptoms—Flutamide—prostate cancer	0.000324	0.011	CcSEcCtD
Cetrorelix—Swelling—Degarelix—prostate cancer	0.000311	0.0106	CcSEcCtD
Cetrorelix—Injection site reaction—Bicalutamide—prostate cancer	0.000304	0.0103	CcSEcCtD
Cetrorelix—Hot flush—Degarelix—prostate cancer	0.000294	0.00995	CcSEcCtD
Cetrorelix—Menopausal symptoms—Degarelix—prostate cancer	0.000291	0.00987	CcSEcCtD
Cetrorelix—Local reaction—Mitoxantrone—prostate cancer	0.000284	0.00962	CcSEcCtD
Cetrorelix—Congenital anomaly—Capecitabine—prostate cancer	0.000277	0.00938	CcSEcCtD
Cetrorelix—Developmental delay—Capecitabine—prostate cancer	0.000277	0.00938	CcSEcCtD
Cetrorelix—Hot flush—Cabazitaxel—prostate cancer	0.000277	0.00938	CcSEcCtD
Cetrorelix—Menopausal symptoms—Cabazitaxel—prostate cancer	0.000274	0.0093	CcSEcCtD
Cetrorelix—Redness—Estradiol—prostate cancer	0.00025	0.00847	CcSEcCtD
Cetrorelix—Hot flush—Bicalutamide—prostate cancer	0.000237	0.00804	CcSEcCtD
Cetrorelix—Menopausal symptoms—Bicalutamide—prostate cancer	0.000235	0.00798	CcSEcCtD
Cetrorelix—Injection site reaction—Goserelin—prostate cancer	0.000212	0.00717	CcSEcCtD
Cetrorelix—Hot flush—Ethinyl Estradiol—prostate cancer	0.000201	0.0068	CcSEcCtD
Cetrorelix—Menopausal symptoms—Ethinyl Estradiol—prostate cancer	0.000199	0.00674	CcSEcCtD
Cetrorelix—Contusion—Estradiol—prostate cancer	0.000193	0.00655	CcSEcCtD
Cetrorelix—Erythema—Flutamide—prostate cancer	0.000184	0.00625	CcSEcCtD
Cetrorelix—Immune system disorder—Estradiol valerate/Dienogest—prostate cancer	0.000181	0.00612	CcSEcCtD
Cetrorelix—Contusion—Mitoxantrone—prostate cancer	0.00018	0.00611	CcSEcCtD
Cetrorelix—Cough—Abiraterone—prostate cancer	0.000177	0.006	CcSEcCtD
Cetrorelix—Swelling—Goserelin—prostate cancer	0.000175	0.00593	CcSEcCtD
Cetrorelix—Swelling—Conjugated Estrogens—prostate cancer	0.000173	0.00588	CcSEcCtD
Cetrorelix—Immune system disorder—Degarelix—prostate cancer	0.000172	0.00582	CcSEcCtD
Cetrorelix—Erythema—Degarelix—prostate cancer	0.000165	0.00561	CcSEcCtD
Cetrorelix—Hot flush—Goserelin—prostate cancer	0.000165	0.0056	CcSEcCtD
Cetrorelix—Menopausal symptoms—Goserelin—prostate cancer	0.000164	0.00555	CcSEcCtD
Cetrorelix—Anaphylactic shock—Estrone—prostate cancer	0.000163	0.00552	CcSEcCtD
Cetrorelix—Immune system disorder—Cabazitaxel—prostate cancer	0.000162	0.00548	CcSEcCtD
Cetrorelix—Cough—Nilutamide—prostate cancer	0.000162	0.00548	CcSEcCtD
Cetrorelix—Redness—Docetaxel—prostate cancer	0.000161	0.00545	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Conjugated Estrogens—prostate cancer	0.000158	0.00536	CcSEcCtD
Cetrorelix—Erythema—Cabazitaxel—prostate cancer	0.000156	0.00528	CcSEcCtD
Cetrorelix—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000142	0.00481	CcSEcCtD
Cetrorelix—Swelling—Estradiol—prostate cancer	0.000139	0.0047	CcSEcCtD
Cetrorelix—Immune system disorder—Bicalutamide—prostate cancer	0.000139	0.0047	CcSEcCtD
Cetrorelix—Cough—Cabazitaxel—prostate cancer	0.000136	0.00461	CcSEcCtD
Cetrorelix—Anaphylactic shock—Degarelix—prostate cancer	0.000135	0.00458	CcSEcCtD
Cetrorelix—Local reaction—Epirubicin—prostate cancer	0.000132	0.00449	CcSEcCtD
Cetrorelix—LHCGR—renal system—prostate cancer	0.000131	0.485	CbGeAlD
Cetrorelix—Hot flush—Estradiol—prostate cancer	0.000131	0.00444	CcSEcCtD
Cetrorelix—Menopausal symptoms—Estradiol—prostate cancer	0.00013	0.0044	CcSEcCtD
Cetrorelix—Swelling—Mitoxantrone—prostate cancer	0.000129	0.00438	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Estradiol—prostate cancer	0.000126	0.00429	CcSEcCtD
Cetrorelix—Hypotension—Degarelix—prostate cancer	0.000126	0.00428	CcSEcCtD
Cetrorelix—Glaucoma—Prednisone—prostate cancer	0.000124	0.00422	CcSEcCtD
Cetrorelix—Local reaction—Doxorubicin—prostate cancer	0.000122	0.00415	CcSEcCtD
Cetrorelix—Contusion—Capecitabine—prostate cancer	0.000121	0.00409	CcSEcCtD
Cetrorelix—Pruritus—Estramustine—prostate cancer	0.000121	0.00409	CcSEcCtD
Cetrorelix—Hypotension—Cabazitaxel—prostate cancer	0.000119	0.00403	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.000118	0.004	CcSEcCtD
Cetrorelix—Immune system disorder—Ethinyl Estradiol—prostate cancer	0.000117	0.00397	CcSEcCtD
Cetrorelix—Cough—Bicalutamide—prostate cancer	0.000117	0.00395	CcSEcCtD
Cetrorelix—Pruritus—Estrone—prostate cancer	0.000115	0.0039	CcSEcCtD
Cetrorelix—Redness—Epirubicin—prostate cancer	0.000109	0.00368	CcSEcCtD
Cetrorelix—Injection site reaction—Docetaxel—prostate cancer	0.000108	0.00366	CcSEcCtD
Cetrorelix—Swelling—Etoposide—prostate cancer	0.000108	0.00365	CcSEcCtD
Cetrorelix—Rash—Estramustine—prostate cancer	0.000107	0.00364	CcSEcCtD
Cetrorelix—Contusion—Prednisone—prostate cancer	0.000107	0.00364	CcSEcCtD
Cetrorelix—Dermatitis—Estramustine—prostate cancer	0.000107	0.00364	CcSEcCtD
Cetrorelix—Pruritus—Nilutamide—prostate cancer	0.000107	0.00362	CcSEcCtD
Cetrorelix—Headache—Estramustine—prostate cancer	0.000107	0.00362	CcSEcCtD
Cetrorelix—Pruritus—Flutamide—prostate cancer	0.000106	0.00361	CcSEcCtD
Cetrorelix—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000105	0.00355	CcSEcCtD
Cetrorelix—Injection site reaction—Capecitabine—prostate cancer	0.000105	0.00354	CcSEcCtD
Cetrorelix—Rash—Abiraterone—prostate cancer	0.000104	0.00354	CcSEcCtD
Cetrorelix—Dermatitis—Abiraterone—prostate cancer	0.000104	0.00353	CcSEcCtD
Cetrorelix—Rash—Estrone—prostate cancer	0.000103	0.00348	CcSEcCtD
Cetrorelix—Dermatitis—Estrone—prostate cancer	0.000103	0.00347	CcSEcCtD
Cetrorelix—Headache—Estrone—prostate cancer	0.000102	0.00346	CcSEcCtD
Cetrorelix—Nausea—Estramustine—prostate cancer	0.000101	0.00343	CcSEcCtD
Cetrorelix—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.0001	0.00341	CcSEcCtD
Cetrorelix—Redness—Doxorubicin—prostate cancer	0.0001	0.0034	CcSEcCtD
Cetrorelix—Hypersensitivity—Degarelix—prostate cancer	9.95e-05	0.00337	CcSEcCtD
Cetrorelix—Cough—Ethinyl Estradiol—prostate cancer	9.86e-05	0.00334	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Etoposide—prostate cancer	9.8e-05	0.00332	CcSEcCtD
Cetrorelix—Nausea—Estrone—prostate cancer	9.67e-05	0.00328	CcSEcCtD
Cetrorelix—Immune system disorder—Goserelin—prostate cancer	9.65e-05	0.00327	CcSEcCtD
Cetrorelix—Immune system disorder—Conjugated Estrogens—prostate cancer	9.56e-05	0.00324	CcSEcCtD
Cetrorelix—Pruritus—Degarelix—prostate cancer	9.55e-05	0.00324	CcSEcCtD
Cetrorelix—Rash—Nilutamide—prostate cancer	9.53e-05	0.00323	CcSEcCtD
Cetrorelix—Dermatitis—Nilutamide—prostate cancer	9.52e-05	0.00323	CcSEcCtD
Cetrorelix—Rash—Flutamide—prostate cancer	9.49e-05	0.00322	CcSEcCtD
Cetrorelix—Dermatitis—Flutamide—prostate cancer	9.48e-05	0.00321	CcSEcCtD
Cetrorelix—Headache—Nilutamide—prostate cancer	9.47e-05	0.00321	CcSEcCtD
Cetrorelix—Headache—Flutamide—prostate cancer	9.43e-05	0.0032	CcSEcCtD
Cetrorelix—Hypersensitivity—Cabazitaxel—prostate cancer	9.37e-05	0.00318	CcSEcCtD
Cetrorelix—Erythema—Goserelin—prostate cancer	9.3e-05	0.00315	CcSEcCtD
Cetrorelix—Erythema—Conjugated Estrogens—prostate cancer	9.21e-05	0.00312	CcSEcCtD
Cetrorelix—Nausea—Nilutamide—prostate cancer	8.98e-05	0.00304	CcSEcCtD
Cetrorelix—Rash—Estradiol valerate/Dienogest—prostate cancer	8.95e-05	0.00304	CcSEcCtD
Cetrorelix—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	8.95e-05	0.00303	CcSEcCtD
Cetrorelix—Swelling—Docetaxel—prostate cancer	8.94e-05	0.00303	CcSEcCtD
Cetrorelix—Nausea—Flutamide—prostate cancer	8.94e-05	0.00303	CcSEcCtD
Cetrorelix—Headache—Estradiol valerate/Dienogest—prostate cancer	8.9e-05	0.00302	CcSEcCtD
Cetrorelix—Swelling—Capecitabine—prostate cancer	8.65e-05	0.00293	CcSEcCtD
Cetrorelix—Rash—Degarelix—prostate cancer	8.51e-05	0.00289	CcSEcCtD
Cetrorelix—Dermatitis—Degarelix—prostate cancer	8.51e-05	0.00288	CcSEcCtD
Cetrorelix—LHCGR—testis—prostate cancer	8.48e-05	0.313	CbGeAlD
Cetrorelix—Headache—Degarelix—prostate cancer	8.46e-05	0.00287	CcSEcCtD
Cetrorelix—Nausea—Estradiol valerate/Dienogest—prostate cancer	8.44e-05	0.00286	CcSEcCtD
Cetrorelix—Hot flush—Docetaxel—prostate cancer	8.43e-05	0.00286	CcSEcCtD
Cetrorelix—Menopausal symptoms—Docetaxel—prostate cancer	8.36e-05	0.00283	CcSEcCtD
Cetrorelix—Hot flush—Capecitabine—prostate cancer	8.16e-05	0.00277	CcSEcCtD
Cetrorelix—Cough—Goserelin—prostate cancer	8.12e-05	0.00275	CcSEcCtD
Cetrorelix—Menopausal symptoms—Capecitabine—prostate cancer	8.09e-05	0.00274	CcSEcCtD
Cetrorelix—Hypersensitivity—Bicalutamide—prostate cancer	8.04e-05	0.00272	CcSEcCtD
Cetrorelix—Cough—Conjugated Estrogens—prostate cancer	8.04e-05	0.00272	CcSEcCtD
Cetrorelix—Nausea—Degarelix—prostate cancer	8.02e-05	0.00272	CcSEcCtD
Cetrorelix—Headache—Cabazitaxel—prostate cancer	7.97e-05	0.0027	CcSEcCtD
Cetrorelix—Pruritus—Bicalutamide—prostate cancer	7.72e-05	0.00262	CcSEcCtD
Cetrorelix—Immune system disorder—Estradiol—prostate cancer	7.65e-05	0.00259	CcSEcCtD
Cetrorelix—Anaphylactic shock—Goserelin—prostate cancer	7.59e-05	0.00257	CcSEcCtD
Cetrorelix—Nausea—Cabazitaxel—prostate cancer	7.56e-05	0.00256	CcSEcCtD
Cetrorelix—Anaphylactic shock—Conjugated Estrogens—prostate cancer	7.52e-05	0.00255	CcSEcCtD
Cetrorelix—Erythema—Estradiol—prostate cancer	7.37e-05	0.0025	CcSEcCtD
Cetrorelix—Injection site reaction—Epirubicin—prostate cancer	7.28e-05	0.00247	CcSEcCtD
Cetrorelix—Hypotension—Goserelin—prostate cancer	7.09e-05	0.0024	CcSEcCtD
Cetrorelix—Hypotension—Conjugated Estrogens—prostate cancer	7.03e-05	0.00238	CcSEcCtD
Cetrorelix—Rash—Bicalutamide—prostate cancer	6.88e-05	0.00233	CcSEcCtD
Cetrorelix—Dermatitis—Bicalutamide—prostate cancer	6.87e-05	0.00233	CcSEcCtD
Cetrorelix—Erythema—Mitoxantrone—prostate cancer	6.87e-05	0.00233	CcSEcCtD
Cetrorelix—Headache—Bicalutamide—prostate cancer	6.84e-05	0.00232	CcSEcCtD
Cetrorelix—Hypersensitivity—Ethinyl Estradiol—prostate cancer	6.8e-05	0.0023	CcSEcCtD
Cetrorelix—Injection site reaction—Doxorubicin—prostate cancer	6.74e-05	0.00228	CcSEcCtD
Cetrorelix—Pruritus—Ethinyl Estradiol—prostate cancer	6.53e-05	0.00221	CcSEcCtD
Cetrorelix—Nausea—Bicalutamide—prostate cancer	6.48e-05	0.0022	CcSEcCtD
Cetrorelix—Cough—Estradiol—prostate cancer	6.43e-05	0.00218	CcSEcCtD
Cetrorelix—Anaphylactic shock—Estradiol—prostate cancer	6.02e-05	0.00204	CcSEcCtD
Cetrorelix—Cough—Mitoxantrone—prostate cancer	5.99e-05	0.00203	CcSEcCtD
Cetrorelix—Immune system disorder—Etoposide—prostate cancer	5.93e-05	0.00201	CcSEcCtD
Cetrorelix—Rash—Ethinyl Estradiol—prostate cancer	5.82e-05	0.00197	CcSEcCtD
Cetrorelix—Dermatitis—Ethinyl Estradiol—prostate cancer	5.81e-05	0.00197	CcSEcCtD
Cetrorelix—Headache—Ethinyl Estradiol—prostate cancer	5.78e-05	0.00196	CcSEcCtD
Cetrorelix—Hot flush—Epirubicin—prostate cancer	5.69e-05	0.00193	CcSEcCtD
Cetrorelix—Menopausal symptoms—Epirubicin—prostate cancer	5.64e-05	0.00191	CcSEcCtD
Cetrorelix—Anaphylactic shock—Mitoxantrone—prostate cancer	5.61e-05	0.0019	CcSEcCtD
Cetrorelix—Hypersensitivity—Goserelin—prostate cancer	5.59e-05	0.0019	CcSEcCtD
Cetrorelix—Hypersensitivity—Conjugated Estrogens—prostate cancer	5.54e-05	0.00188	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Epirubicin—prostate cancer	5.5e-05	0.00186	CcSEcCtD
Cetrorelix—Nausea—Ethinyl Estradiol—prostate cancer	5.48e-05	0.00186	CcSEcCtD
Cetrorelix—GNRHR—testis—prostate cancer	5.47e-05	0.202	CbGeAlD
Cetrorelix—Pruritus—Goserelin—prostate cancer	5.37e-05	0.00182	CcSEcCtD
Cetrorelix—Pruritus—Conjugated Estrogens—prostate cancer	5.32e-05	0.0018	CcSEcCtD
Cetrorelix—Hot flush—Doxorubicin—prostate cancer	5.26e-05	0.00178	CcSEcCtD
Cetrorelix—Hypotension—Mitoxantrone—prostate cancer	5.24e-05	0.00178	CcSEcCtD
Cetrorelix—Menopausal symptoms—Doxorubicin—prostate cancer	5.22e-05	0.00177	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Doxorubicin—prostate cancer	5.08e-05	0.00172	CcSEcCtD
Cetrorelix—Cough—Etoposide—prostate cancer	4.99e-05	0.00169	CcSEcCtD
Cetrorelix—Immune system disorder—Docetaxel—prostate cancer	4.93e-05	0.00167	CcSEcCtD
Cetrorelix—Rash—Goserelin—prostate cancer	4.79e-05	0.00162	CcSEcCtD
Cetrorelix—Dermatitis—Goserelin—prostate cancer	4.78e-05	0.00162	CcSEcCtD
Cetrorelix—Immune system disorder—Capecitabine—prostate cancer	4.77e-05	0.00162	CcSEcCtD
Cetrorelix—Headache—Goserelin—prostate cancer	4.76e-05	0.00161	CcSEcCtD
Cetrorelix—Erythema—Docetaxel—prostate cancer	4.75e-05	0.00161	CcSEcCtD
Cetrorelix—Rash—Conjugated Estrogens—prostate cancer	4.74e-05	0.00161	CcSEcCtD
Cetrorelix—Dermatitis—Conjugated Estrogens—prostate cancer	4.74e-05	0.00161	CcSEcCtD
Cetrorelix—Headache—Conjugated Estrogens—prostate cancer	4.71e-05	0.0016	CcSEcCtD
Cetrorelix—Anaphylactic shock—Etoposide—prostate cancer	4.66e-05	0.00158	CcSEcCtD
Cetrorelix—Erythema—Capecitabine—prostate cancer	4.6e-05	0.00156	CcSEcCtD
Cetrorelix—Nausea—Goserelin—prostate cancer	4.51e-05	0.00153	CcSEcCtD
Cetrorelix—Nausea—Conjugated Estrogens—prostate cancer	4.47e-05	0.00151	CcSEcCtD
Cetrorelix—Hypersensitivity—Estradiol—prostate cancer	4.43e-05	0.0015	CcSEcCtD
Cetrorelix—Hypotension—Etoposide—prostate cancer	4.36e-05	0.00148	CcSEcCtD
Cetrorelix—Pruritus—Estradiol—prostate cancer	4.26e-05	0.00144	CcSEcCtD
Cetrorelix—Immune system disorder—Prednisone—prostate cancer	4.25e-05	0.00144	CcSEcCtD
Cetrorelix—Cough—Docetaxel—prostate cancer	4.14e-05	0.0014	CcSEcCtD
Cetrorelix—Hypersensitivity—Mitoxantrone—prostate cancer	4.13e-05	0.0014	CcSEcCtD
Cetrorelix—Erythema—Prednisone—prostate cancer	4.1e-05	0.00139	CcSEcCtD
Cetrorelix—Cough—Capecitabine—prostate cancer	4.01e-05	0.00136	CcSEcCtD
Cetrorelix—Anaphylactic shock—Docetaxel—prostate cancer	3.88e-05	0.00131	CcSEcCtD
Cetrorelix—Rash—Estradiol—prostate cancer	3.79e-05	0.00129	CcSEcCtD
Cetrorelix—Dermatitis—Estradiol—prostate cancer	3.79e-05	0.00128	CcSEcCtD
Cetrorelix—Headache—Estradiol—prostate cancer	3.77e-05	0.00128	CcSEcCtD
Cetrorelix—Hypotension—Docetaxel—prostate cancer	3.62e-05	0.00123	CcSEcCtD
Cetrorelix—Nausea—Estradiol—prostate cancer	3.57e-05	0.00121	CcSEcCtD
Cetrorelix—Rash—Mitoxantrone—prostate cancer	3.54e-05	0.0012	CcSEcCtD
Cetrorelix—Dermatitis—Mitoxantrone—prostate cancer	3.53e-05	0.0012	CcSEcCtD
Cetrorelix—Headache—Mitoxantrone—prostate cancer	3.51e-05	0.00119	CcSEcCtD
Cetrorelix—Hypotension—Capecitabine—prostate cancer	3.51e-05	0.00119	CcSEcCtD
Cetrorelix—Hypersensitivity—Etoposide—prostate cancer	3.44e-05	0.00116	CcSEcCtD
Cetrorelix—Anaphylactic shock—Prednisone—prostate cancer	3.34e-05	0.00113	CcSEcCtD
Cetrorelix—Nausea—Mitoxantrone—prostate cancer	3.33e-05	0.00113	CcSEcCtD
Cetrorelix—Immune system disorder—Epirubicin—prostate cancer	3.32e-05	0.00113	CcSEcCtD
Cetrorelix—Pruritus—Etoposide—prostate cancer	3.3e-05	0.00112	CcSEcCtD
Cetrorelix—Erythema—Epirubicin—prostate cancer	3.2e-05	0.00109	CcSEcCtD
Cetrorelix—Immune system disorder—Doxorubicin—prostate cancer	3.08e-05	0.00104	CcSEcCtD
Cetrorelix—Erythema—Doxorubicin—prostate cancer	2.96e-05	0.001	CcSEcCtD
Cetrorelix—Rash—Etoposide—prostate cancer	2.94e-05	0.000997	CcSEcCtD
Cetrorelix—Dermatitis—Etoposide—prostate cancer	2.94e-05	0.000996	CcSEcCtD
Cetrorelix—Headache—Etoposide—prostate cancer	2.92e-05	0.00099	CcSEcCtD
Cetrorelix—Hypersensitivity—Docetaxel—prostate cancer	2.86e-05	0.000968	CcSEcCtD
Cetrorelix—Cough—Epirubicin—prostate cancer	2.8e-05	0.000947	CcSEcCtD
Cetrorelix—Nausea—Etoposide—prostate cancer	2.77e-05	0.000939	CcSEcCtD
Cetrorelix—Hypersensitivity—Capecitabine—prostate cancer	2.76e-05	0.000937	CcSEcCtD
Cetrorelix—Pruritus—Docetaxel—prostate cancer	2.74e-05	0.000929	CcSEcCtD
Cetrorelix—Pruritus—Capecitabine—prostate cancer	2.65e-05	0.0009	CcSEcCtD
Cetrorelix—Anaphylactic shock—Epirubicin—prostate cancer	2.61e-05	0.000886	CcSEcCtD
Cetrorelix—Cough—Doxorubicin—prostate cancer	2.59e-05	0.000877	CcSEcCtD
Cetrorelix—Hypersensitivity—Prednisone—prostate cancer	2.46e-05	0.000835	CcSEcCtD
Cetrorelix—Rash—Docetaxel—prostate cancer	2.44e-05	0.000828	CcSEcCtD
Cetrorelix—Hypotension—Epirubicin—prostate cancer	2.44e-05	0.000828	CcSEcCtD
Cetrorelix—Dermatitis—Docetaxel—prostate cancer	2.44e-05	0.000828	CcSEcCtD
Cetrorelix—Headache—Docetaxel—prostate cancer	2.43e-05	0.000823	CcSEcCtD
Cetrorelix—Anaphylactic shock—Doxorubicin—prostate cancer	2.42e-05	0.00082	CcSEcCtD
Cetrorelix—Rash—Capecitabine—prostate cancer	2.37e-05	0.000802	CcSEcCtD
Cetrorelix—Pruritus—Prednisone—prostate cancer	2.36e-05	0.000802	CcSEcCtD
Cetrorelix—Dermatitis—Capecitabine—prostate cancer	2.36e-05	0.000801	CcSEcCtD
Cetrorelix—Headache—Capecitabine—prostate cancer	2.35e-05	0.000797	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—VAV3—prostate cancer	2.32e-05	0.000983	CbGpPWpGaD
Cetrorelix—Nausea—Docetaxel—prostate cancer	2.3e-05	0.00078	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—PRKCQ—prostate cancer	2.3e-05	0.000973	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VIP—prostate cancer	2.29e-05	0.000967	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—GNRH1—prostate cancer	2.29e-05	0.000967	CbGpPWpGaD
Cetrorelix—Hypotension—Doxorubicin—prostate cancer	2.26e-05	0.000766	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—GNG5—prostate cancer	2.25e-05	0.000953	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—ITPR1—prostate cancer	2.25e-05	0.000953	CbGpPWpGaD
Cetrorelix—Nausea—Capecitabine—prostate cancer	2.23e-05	0.000756	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GRP—prostate cancer	2.21e-05	0.000936	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LPAR1—prostate cancer	2.21e-05	0.000936	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PLCB2—prostate cancer	2.19e-05	0.000927	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LRP2—prostate cancer	2.19e-05	0.000927	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—ADRB2—prostate cancer	2.16e-05	0.000915	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PTHLH—prostate cancer	2.16e-05	0.000914	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—P4HB—prostate cancer	2.15e-05	0.000909	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CX3CL1—prostate cancer	2.15e-05	0.000909	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JUP—prostate cancer	2.12e-05	0.000895	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—WNT4—prostate cancer	2.12e-05	0.000895	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—VAV3—prostate cancer	2.11e-05	0.000892	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HIST1H2BG—prostate cancer	2.11e-05	0.000892	CbGpPWpGaD
Cetrorelix—Rash—Prednisone—prostate cancer	2.11e-05	0.000714	CcSEcCtD
Cetrorelix—Dermatitis—Prednisone—prostate cancer	2.11e-05	0.000714	CcSEcCtD
Cetrorelix—Headache—Prednisone—prostate cancer	2.09e-05	0.00071	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—PDE4D—prostate cancer	2.09e-05	0.000884	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—GRB7—prostate cancer	2.09e-05	0.000884	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—ITPR1—prostate cancer	2.05e-05	0.000866	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HIST1H4H—prostate cancer	2.04e-05	0.000862	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—CXCL8—prostate cancer	2.04e-05	0.000861	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ANXA1—prostate cancer	2.03e-05	0.00086	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RALBP1—prostate cancer	2.02e-05	0.000854	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MC2R—prostate cancer	2.02e-05	0.000854	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—GNG5—prostate cancer	1.99e-05	0.000841	CbGpPWpGaD
Cetrorelix—Nausea—Prednisone—prostate cancer	1.99e-05	0.000673	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PTHLH—prostate cancer	1.96e-05	0.00083	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Epirubicin—prostate cancer	1.93e-05	0.000653	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PRKACB—prostate cancer	1.92e-05	0.000813	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CALCA—prostate cancer	1.9e-05	0.000805	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PPP3CA—prostate cancer	1.87e-05	0.000792	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CXCL12—prostate cancer	1.86e-05	0.000786	CbGpPWpGaD
Cetrorelix—Pruritus—Epirubicin—prostate cancer	1.85e-05	0.000627	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—ANXA1—prostate cancer	1.85e-05	0.000781	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PENK—prostate cancer	1.8e-05	0.000761	CbGpPWpGaD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.79e-05	0.000757	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Doxorubicin—prostate cancer	1.78e-05	0.000604	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	1.77e-05	0.000747	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TGFBR1—prostate cancer	1.73e-05	0.000733	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PTHLH—prostate cancer	1.73e-05	0.000733	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CALCA—prostate cancer	1.73e-05	0.000731	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GHR—prostate cancer	1.72e-05	0.000726	CbGpPWpGaD
Cetrorelix—GNRHR—G alpha (q) signalling events—PIK3CA—prostate cancer	1.71e-05	0.000725	CbGpPWpGaD
Cetrorelix—Pruritus—Doxorubicin—prostate cancer	1.71e-05	0.00058	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—AKR1C3—prostate cancer	1.7e-05	0.000721	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PRKCQ—prostate cancer	1.7e-05	0.000718	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PRKACB—prostate cancer	1.69e-05	0.000717	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CXCL12—prostate cancer	1.69e-05	0.000714	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	1.67e-05	0.000706	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—THBS1—prostate cancer	1.65e-05	0.000699	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PPP3CA—prostate cancer	1.65e-05	0.000699	CbGpPWpGaD
Cetrorelix—Rash—Epirubicin—prostate cancer	1.65e-05	0.000559	CcSEcCtD
Cetrorelix—Dermatitis—Epirubicin—prostate cancer	1.65e-05	0.000558	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—NRP1—prostate cancer	1.65e-05	0.000696	CbGpPWpGaD
Cetrorelix—Headache—Epirubicin—prostate cancer	1.64e-05	0.000555	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—ANXA1—prostate cancer	1.63e-05	0.000689	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PRKCZ—prostate cancer	1.6e-05	0.000676	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ADRB2—prostate cancer	1.59e-05	0.000675	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CG—prostate cancer	1.56e-05	0.000661	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—VAV3—prostate cancer	1.56e-05	0.000658	CbGpPWpGaD
Cetrorelix—Nausea—Epirubicin—prostate cancer	1.55e-05	0.000526	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—PARP1—prostate cancer	1.54e-05	0.000653	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGFR4—prostate cancer	1.54e-05	0.000653	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PRKCQ—prostate cancer	1.54e-05	0.000652	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	1.53e-05	0.000649	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VIP—prostate cancer	1.53e-05	0.000647	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GNRH1—prostate cancer	1.53e-05	0.000647	CbGpPWpGaD
Cetrorelix—Rash—Doxorubicin—prostate cancer	1.53e-05	0.000517	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—CALCA—prostate cancer	1.52e-05	0.000645	CbGpPWpGaD
Cetrorelix—Dermatitis—Doxorubicin—prostate cancer	1.52e-05	0.000516	CcSEcCtD
Cetrorelix—Headache—Doxorubicin—prostate cancer	1.52e-05	0.000514	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—ITPR1—prostate cancer	1.51e-05	0.000638	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCL12—prostate cancer	1.49e-05	0.00063	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LPAR1—prostate cancer	1.48e-05	0.000627	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GRP—prostate cancer	1.48e-05	0.000627	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PLCB2—prostate cancer	1.47e-05	0.000621	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LRP2—prostate cancer	1.47e-05	0.000621	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—ADRB2—prostate cancer	1.45e-05	0.000613	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—P4HB—prostate cancer	1.44e-05	0.000609	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CX3CL1—prostate cancer	1.44e-05	0.000609	CbGpPWpGaD
Cetrorelix—Nausea—Doxorubicin—prostate cancer	1.44e-05	0.000487	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CG—prostate cancer	1.42e-05	0.0006	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—VAV3—prostate cancer	1.41e-05	0.000597	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIST1H2BG—prostate cancer	1.41e-05	0.000597	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CASP9—prostate cancer	1.4e-05	0.000593	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GRB7—prostate cancer	1.4e-05	0.000592	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PDE4D—prostate cancer	1.4e-05	0.000592	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CD—prostate cancer	1.37e-05	0.000581	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—ITPR1—prostate cancer	1.37e-05	0.000579	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIST1H4H—prostate cancer	1.36e-05	0.000577	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—CXCL8—prostate cancer	1.36e-05	0.000577	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PRKCQ—prostate cancer	1.36e-05	0.000575	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NGFR—prostate cancer	1.36e-05	0.000575	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	1.36e-05	0.000574	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAP3K7—prostate cancer	1.34e-05	0.000568	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GNG5—prostate cancer	1.33e-05	0.000563	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGF10—prostate cancer	1.29e-05	0.000546	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ADRB2—prostate cancer	1.28e-05	0.000541	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—JAK2—prostate cancer	1.26e-05	0.000533	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—MAP2K1—prostate cancer	1.26e-05	0.000531	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CD—prostate cancer	1.25e-05	0.000528	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VAV3—prostate cancer	1.25e-05	0.000527	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TGFBR2—prostate cancer	1.23e-05	0.00052	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ITPR1—prostate cancer	1.21e-05	0.000511	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CB—prostate cancer	1.2e-05	0.000506	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TGFBR1—prostate cancer	1.16e-05	0.000491	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTHLH—prostate cancer	1.16e-05	0.000491	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF1R—prostate cancer	1.16e-05	0.000489	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—CXCL8—prostate cancer	1.15e-05	0.000487	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—JAK2—prostate cancer	1.14e-05	0.000484	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKR1C3—prostate cancer	1.14e-05	0.000483	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PRKACB—prostate cancer	1.13e-05	0.00048	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LPL—prostate cancer	1.11e-05	0.000469	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PPP3CA—prostate cancer	1.11e-05	0.000468	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—THBS1—prostate cancer	1.11e-05	0.000468	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—IL2—prostate cancer	1.1e-05	0.000465	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PDGFRB—prostate cancer	1.1e-05	0.000465	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ANXA1—prostate cancer	1.09e-05	0.000461	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CB—prostate cancer	1.09e-05	0.00046	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ITGB3—prostate cancer	1.07e-05	0.000453	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PRKCZ—prostate cancer	1.07e-05	0.000453	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CG—prostate cancer	1.05e-05	0.000442	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—CXCL8—prostate cancer	1.04e-05	0.000442	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB3—prostate cancer	1.04e-05	0.000439	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGFR2—prostate cancer	1.04e-05	0.000438	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PARP1—prostate cancer	1.03e-05	0.000437	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGFR4—prostate cancer	1.03e-05	0.000437	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CALCA—prostate cancer	1.02e-05	0.000432	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL2—prostate cancer	9.98e-06	0.000422	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL12—prostate cancer	9.97e-06	0.000422	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TERT—prostate cancer	9.95e-06	0.000421	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HIF1A—prostate cancer	9.51e-06	0.000402	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CG—prostate cancer	9.5e-06	0.000402	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CASP9—prostate cancer	9.39e-06	0.000397	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—LEP—prostate cancer	9.29e-06	0.000393	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CAV1—prostate cancer	9.2e-06	0.000389	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CD—prostate cancer	9.19e-06	0.000389	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PRKCQ—prostate cancer	9.1e-06	0.000385	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KDR—prostate cancer	9.1e-06	0.000385	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NGFR—prostate cancer	9.1e-06	0.000385	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAP3K7—prostate cancer	8.99e-06	0.00038	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ESR1—prostate cancer	8.87e-06	0.000375	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—BAD—prostate cancer	8.65e-06	0.000366	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF10—prostate cancer	8.64e-06	0.000366	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ADRB2—prostate cancer	8.55e-06	0.000362	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—JAK2—prostate cancer	8.44e-06	0.000357	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MAP2K1—prostate cancer	8.41e-06	0.000356	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—APC—prostate cancer	8.38e-06	0.000355	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CG—prostate cancer	8.38e-06	0.000355	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CD—prostate cancer	8.35e-06	0.000353	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VAV3—prostate cancer	8.34e-06	0.000353	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGF—prostate cancer	8.28e-06	0.00035	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IRS1—prostate cancer	8.28e-06	0.00035	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TGFBR2—prostate cancer	8.22e-06	0.000348	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ITPR1—prostate cancer	8.09e-06	0.000342	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—GSK3B—prostate cancer	8.04e-06	0.00034	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CB—prostate cancer	8.01e-06	0.000339	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—INS—prostate cancer	7.93e-06	0.000336	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CREBBP—prostate cancer	7.77e-06	0.000329	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF1R—prostate cancer	7.74e-06	0.000327	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CXCL8—prostate cancer	7.7e-06	0.000326	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF1—prostate cancer	7.67e-06	0.000325	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—JAK2—prostate cancer	7.66e-06	0.000324	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—EGFR—prostate cancer	7.64e-06	0.000323	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAP2K1—prostate cancer	7.42e-06	0.000314	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LPL—prostate cancer	7.42e-06	0.000314	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CD—prostate cancer	7.37e-06	0.000312	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—IL2—prostate cancer	7.36e-06	0.000311	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PDGFRB—prostate cancer	7.35e-06	0.000311	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CA—prostate cancer	7.3e-06	0.000309	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SERPINE1—prostate cancer	7.29e-06	0.000308	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CB—prostate cancer	7.28e-06	0.000308	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—KRAS—prostate cancer	7.21e-06	0.000305	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ITGB3—prostate cancer	7.16e-06	0.000303	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGF2—prostate cancer	7.05e-06	0.000298	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CXCL8—prostate cancer	6.99e-06	0.000296	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NOS3—prostate cancer	6.96e-06	0.000294	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB3—prostate cancer	6.95e-06	0.000294	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGFR2—prostate cancer	6.94e-06	0.000293	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—JAK2—prostate cancer	6.76e-06	0.000286	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL2—prostate cancer	6.68e-06	0.000283	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TERT—prostate cancer	6.66e-06	0.000282	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CA—prostate cancer	6.63e-06	0.00028	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MDM2—prostate cancer	6.6e-06	0.000279	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB2—prostate cancer	6.51e-06	0.000275	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CB—prostate cancer	6.42e-06	0.000272	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIF1A—prostate cancer	6.37e-06	0.000269	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—LEP—prostate cancer	6.22e-06	0.000263	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCL8—prostate cancer	6.17e-06	0.000261	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CAV1—prostate cancer	6.16e-06	0.000261	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KDR—prostate cancer	6.09e-06	0.000258	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN1B—prostate cancer	6.03e-06	0.000255	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—AKT1—prostate cancer	5.96e-06	0.000252	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ESR1—prostate cancer	5.94e-06	0.000251	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CASP3—prostate cancer	5.91e-06	0.00025	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL2—prostate cancer	5.9e-06	0.00025	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL6—prostate cancer	5.87e-06	0.000248	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—BAD—prostate cancer	5.79e-06	0.000245	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CCND1—prostate cancer	5.75e-06	0.000243	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CTNNB1—prostate cancer	5.69e-06	0.000241	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—APC—prostate cancer	5.61e-06	0.000237	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CG—prostate cancer	5.61e-06	0.000237	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MMP9—prostate cancer	5.58e-06	0.000236	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN1A—prostate cancer	5.56e-06	0.000235	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PTEN—prostate cancer	5.55e-06	0.000235	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGF—prostate cancer	5.55e-06	0.000235	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IRS1—prostate cancer	5.55e-06	0.000235	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—AKT1—prostate cancer	5.41e-06	0.000229	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GSK3B—prostate cancer	5.38e-06	0.000228	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—INS—prostate cancer	5.31e-06	0.000225	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EP300—prostate cancer	5.29e-06	0.000224	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CREBBP—prostate cancer	5.2e-06	0.00022	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SRC—prostate cancer	5.15e-06	0.000218	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF1—prostate cancer	5.14e-06	0.000217	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—EGFR—prostate cancer	5.11e-06	0.000216	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VEGFA—prostate cancer	5.01e-06	0.000212	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAP2K1—prostate cancer	4.97e-06	0.00021	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—STAT3—prostate cancer	4.96e-06	0.00021	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CD—prostate cancer	4.93e-06	0.000209	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CA—prostate cancer	4.89e-06	0.000207	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SERPINE1—prostate cancer	4.88e-06	0.000206	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—KRAS—prostate cancer	4.83e-06	0.000204	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF2—prostate cancer	4.72e-06	0.0002	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOS3—prostate cancer	4.66e-06	0.000197	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MYC—prostate cancer	4.61e-06	0.000195	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TGFB1—prostate cancer	4.6e-06	0.000195	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JAK2—prostate cancer	4.53e-06	0.000192	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGFR—prostate cancer	4.51e-06	0.000191	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CA—prostate cancer	4.44e-06	0.000188	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MDM2—prostate cancer	4.42e-06	0.000187	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB2—prostate cancer	4.36e-06	0.000184	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CB—prostate cancer	4.3e-06	0.000182	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KRAS—prostate cancer	4.26e-06	0.00018	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL8—prostate cancer	4.13e-06	0.000175	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN1B—prostate cancer	4.03e-06	0.000171	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—AKT1—prostate cancer	3.99e-06	0.000169	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CASP3—prostate cancer	3.95e-06	0.000167	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL2—prostate cancer	3.95e-06	0.000167	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL6—prostate cancer	3.93e-06	0.000166	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CA—prostate cancer	3.92e-06	0.000166	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CCND1—prostate cancer	3.85e-06	0.000163	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CTNNB1—prostate cancer	3.81e-06	0.000161	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TP53—prostate cancer	3.79e-06	0.00016	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MMP9—prostate cancer	3.74e-06	0.000158	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN1A—prostate cancer	3.72e-06	0.000158	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTEN—prostate cancer	3.72e-06	0.000157	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AKT1—prostate cancer	3.62e-06	0.000153	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EP300—prostate cancer	3.54e-06	0.00015	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL6—prostate cancer	3.47e-06	0.000147	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SRC—prostate cancer	3.45e-06	0.000146	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFA—prostate cancer	3.36e-06	0.000142	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—STAT3—prostate cancer	3.32e-06	0.000141	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AKT1—prostate cancer	3.2e-06	0.000135	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MYC—prostate cancer	3.09e-06	0.000131	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TGFB1—prostate cancer	3.08e-06	0.00013	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGFR—prostate cancer	3.02e-06	0.000128	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KRAS—prostate cancer	2.85e-06	0.000121	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CA—prostate cancer	2.62e-06	0.000111	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TP53—prostate cancer	2.54e-06	0.000107	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL6—prostate cancer	2.32e-06	9.82e-05	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKT1—prostate cancer	2.14e-06	9.06e-05	CbGpPWpGaD
